CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
47.69
-2.40 (-4.79%)
At close: Mar 18, 2026, 4:00 PM EDT
47.56
-0.13 (-0.27%)
After-hours: Mar 18, 2026, 7:59 PM EDT
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $4.58 billion as of March 18, 2026. Its market cap has increased by 26.19% in one year.
Market Cap
4.58B
Enterprise Value
2.81B
1-Year Change
26.19%
Ranking
Category
Stock Price
$47.69
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $4.58B, an increase of 717.27%. That is a compound annual growth rate of 25.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 4.81B | -3.79% |
| Dec 31, 2025 | 5.00B | 48.76% |
| Dec 31, 2024 | 3.36B | -32.44% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
| Oct 19, 2016 | 560.10M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caris Life Sciences | 5.38B |
| Xenon Pharmaceuticals | 5.29B |
| Celcuity | 5.29B |
| Immunovant | 5.12B |
| TG Therapeutics | 4.88B |
| Apogee Therapeutics | 4.85B |
| Scholar Rock Holding | 4.68B |
| Amicus Therapeutics | 4.52B |